Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 9873793

Factor VIII immunogenicity.

M G Jacquemin·J M Saint-Remy
View original source ↗Export metadata ↓

Abstract

The immunogenicity of factor VIII depends on the interaction of multiple parametres including host susceptibility and characteristics of the factor VIII preparations. We briefly review here the basic mechanisms by which tolerance to self is established, maintained, and possibly broken in the context of haemophilia A, with special emphasis on the severity of the disease. Reference is also made to the situation observed in healthy individuals and patients with autoantibodies to factor VIII.

Explore related subjects

Antibody FormationAutoimmunityFactor VIIIHemophilia AHumansImmune ToleranceJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M G Jacquemin, J M Saint-Remy. 1998. Factor VIII immunogenicity.. https://doi.org/10.1046/j.1365-2516.1998.440552.x

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2002

Microarray analysis of B-cell stimulation.

B-cell development to antibody-producing plasma cells requires the concerted function of a large number of genes and proteins. Genome-level expression profiling during human B-cell maturation was studied in anti-immunoglobulin M-stimulated Ramos cells. cDNA microarrays were used to follow changes in the transcriptome over several days. Close to 1500 genes had significantly altered expression at least at one time point. The genes were organized into clusters based on expression profiles and were further characterized based on the functions of the coded proteins. Several groups of genes important for B cells were analyzed. Here we concentrate on genes involved in signal transduction and cytokines and their receptors. The results provide knowledge on the development of humoral immunity. Several new genes were found to be essential for B-cell development. They can be used as targets for research and possibly for drug development.

Antibody Formation↗
PubMed2002

Mycophenolate mofetil decreases antibody production after cardiac transplantation.

New immunosuppressive drugs are extensively being investigated for their effect on T-cell immunity, with far less being known about their effect on the humoral immune response. In view of the experimental and clinical evidence that humoral immunity contributes to acute and chronic rejection, we investigated post-transplant production of anti-vimentin and anti-HLA antibodies in 86 patients who were part of a worldwide clinical trial for mycophenolate mofetil in cardiac transplantation. The results demonstrate that patients taking MMF instead of azathioprine generated significantly fewer de novo anti-vimentin antibodies.

Antibody Formation↗